HAMMOND v. KENVUE INC. et al
Case Number:
3:23-cv-20998
Court:
Nature of Suit:
Judge:
Firms
Companies
- Academy Securities Inc.
- BNP Paribas SA
- Citigroup Inc.
- Deutsche Bank AG
- HSBC Holdings PLC
- Intesa Sanpaolo SpA
- Johnson & Johnson
- JPMorgan Chase & Co.
- Kenvue Inc.
- RBC Capital Markets
- Santander Holdings USA Inc.
- Siebert Williams Shank & Co. LLC
- The Goldman Sachs Group Inc.
- UBS Group AG
- UniCredit
Sectors & Industries:
-
May 07, 2025
Investors Fight J&J, Kenvue Bid To Nix IPO Fraud Suit
A New Jersey federal judge shouldn't reconsider his decision to sustain IPO fraud claims against pharmaceutical giant Johnson & Johnson and a former subsidiary, investors suing the companies said Wednesday by arguing that the judge was right to find that the companies should have disclosed a "serious challenge" to the effectiveness of a common medication ingredient in public filings.
-
March 25, 2025
UBH Patients On Remand, CMS Audits And J&J Investor Suit
Patients challenging United Behavioral Health coverage guidelines for mental health treatment filed their first brief in the case since the Ninth Circuit clarified the scope of the remanded proceedings.
-
March 24, 2025
Kenvue, J&J Must Face Investor Suit Over FDA Concerns
Consumer health products business Kenvue Inc. and former parent company Johnson & Johnson cannot escape a consolidated lawsuit accusing the companies of failing to warn investors about the potential ineffectiveness of leading products like Tylenol and Sudafed ahead of Kenvue's initial public offering, a New Jersey federal judge ruled on Monday.